US10676512B2ActiveUtilityPatentIndex 40
Microorganism with enhanced L-lysine producibility and method for producing L-lysine using the same
Est. expirySep 5, 2034(~8.2 yrs left)· nominal 20-yr term from priority
C07K 14/34C12P 13/08C12Y 207/07006C12N 9/12C12R 1/15C12N 1/205C12R 2001/15C12N 15/52C12N 9/1247C12N 1/20
40
PatentIndex Score
0
Cited by
12
References
7
Claims
Abstract
The present disclosure relates to a novel modified RNA polymerase sigma factor A (SigA) polypeptide; a polynucleotide encoding the same; a microorganism containing the polypeptide; and a method for producing L-lysine using the microorganism.
Claims
exact text as granted — not AI-modifiedThe invention claimed is:
1. A modified polypeptide having RNA polymerase sigma factor A activity and the amino acid sequence set forth in SEQ ID NO: 2 but with one or two amino acid substitutions, wherein at least one of the one or two amino acid substitutions is selected from the group consisting of a substitution of the 136 th amino acid with glycine; a substitution of the 254 th amino acid with asparagine; a substitution of the 268 th amino acid with serine; a substitution of the 281 st amino acid with serine; a substitution of the 381 st amino acid with arginine; a substitution of the 429 th amino acid with arginine; a substitution of the 447 th amino acid with histidine; a substitution of the 451 st amino acid with isoleucine; a substitution of the 455 th amino acid with valine; a substitution of the 479 th amino acid with arginine; a substitution of the 483 rd amino acid with arginine; a substitution of the 488 th amino acid with threonine; and a substitution of the 491 st amino acid with arginine.
2. The modified polypeptide according to claim 1 , wherein the modified polypeptide has an amino acid sequence selected from the group consisting of the amino acid sequences set forth in SEQ ID NOS: 12 to 22.
3. A polynucleotide encoding the modified polypeptide of claim 1 .
4. A host cell comprising the polynucleotide of claim 3 .
5. A microorganism of the genus Corynebacterium having enhanced L-lysine producibility, comprising a modified polypeptide having RNA polymerase sigma factor A activity and the amino acid sequence set forth in SEQ ID NO: 2 but with one or two substitutions in SEQ ID NO:2, wherein at least one of the one or two substitutions is selected from the group consisting of a substitution of the 136 th amino acid with glycine; a substitution of the 254 th amino acid with asparagine; a substitution of the 268 th amino acid with serine; a substitution of the 281 st amino acid with serine; a substitution of the 381 st amino acid with arginine; a substitution of the 429 th amino acid with arginine; a substitution of the 447 th amino acid with histidine; a substitution of the 451 st amino acid with isoleucine; a substitution of the 455 th amino acid with valine; a substitution of the 479 th amino acid with arginine; a substitution of the 483 rd amino acid with arginine; a substitution of the 488 th amino acid with threonine; and a substitution of the 491 st amino acid with arginine.
6. The microorganism according to claim 5 , wherein the microorganism is Corynebacterium glutamicum.
7. A method for producing L-lysine, comprising:
(a) culturing the microorganism according to claim 5 in a medium; and
(b) recovering L-lysine from the cultured microorganism or the cultured medium.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.